Edition:
United States

OpGen Inc (OPGN.OQ)

OPGN.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
3:59pm EST
Change (% chg)

$-0.01 (-3.70%)
Prev Close
$0.23
Open
$0.23
Day's High
$0.23
Day's Low
$0.22
Volume
88,151
Avg. Vol
278,368
52-wk High
$3.10
52-wk Low
$0.20

Chart for

About

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening... (more)

Overall

Beta: --
Market Cap(Mil.): $12.62
Shares Outstanding(Mil.): 54.87
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Opgen reports 2017 third quarter financial results

* Opgen reports 2017 third quarter financial results and provides business update

Nov 07 2017

BRIEF-OpGen Q2 loss per share $0.15​

* OpGen reports 2017 second quarter financial results and provides business update

Aug 08 2017

BRIEF-Opgen ‍prices public offering to issue and sell 18.2 mln units

* Opgen Inc - ‍priced a public offering to issue and sell 18.2 million units at an offering price per unit of $0.40​ Source: (http://bit.ly/2tUCOHV) Further company coverage:

Jul 14 2017

BRIEF-Opgen announces pricing of $10.0 million public offering

* Units are being offered at a price of $0.40 per unit. Source text for Eikon: Further company coverage:

Jul 13 2017

BRIEF-Opgen files for offering up to 13.7 mln shares of co's common stock

* Opgen Inc files for offering up to 13.7 million shares of co's common stock and common warrants to purchase aggregate of 6.85 million shares of co's common stock Source text - http://bit.ly/2sUa439 Further company coverage:

Jun 29 2017

BRIEF-OpGen signs supply agreement to use Thermo Fisher Scientific’S technology

* Opgen signs supply agreement to use thermo fisher scientific’s technology to advance acuitas® rapid test

Jun 19 2017

Earnings vs. Estimates